VEA
MGNX icon

Virtus ETF Advisers’s MacroGenics MGNX Stock Holding History

Virtus ETF Advisers’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-19,694
Closed -$64.8K – 490
2024
Q3 		$64.8K Buy
19,694
+351
+2% +$1.37K 0.03% 434
2024
Q2 		$82.2K Buy
19,343
+10,034
+108% +$97.7K 0.04% 395
2024
Q1 		$137K Sell
9,309
-635
-6% -$9.6K 0.07% 336
2023
Q4 		$95.7K Buy
+9,944
New +$68.7K 0.06% 381
2022
Q2 		– Sell
-9,556
Closed -$84K – 461
2022
Q1 		$84K Sell
9,556
-564
-6% -$6.23K 0.04% 331
2021
Q4 		$162K Sell
10,120
-93
-0.9% -$1.75K 0.06% 321
2021
Q3 		$214K Sell
10,213
-541
-5% -$13K 0.09% 253
2021
Q2 		$289K Sell
10,754
-1,894
-15% -$55.5K 0.12% 202
2021
Q1 		$403K Buy
12,648
+229
+2% +$5.56K 0.17% 180
2020
Q4 		$284K Sell
12,419
-2,965
-19% -$68.3K 0.12% 237
2020
Q3 		$388K Sell
15,384
-2,100
-12% -$57.3K 0.2% 175
2020
Q2 		$488K Sell
17,484
-16,459
-48% -$286K 0.23% 151
2020
Q1 		$198K Sell
33,943
-4,962
-13% -$45.1K 0.08% 277
2019
Q4 		$423K Buy
38,905
+22,311
+134% +$221K 0.07% 240
2019
Q3 		$212K Sell
16,594
-925
-5% -$13.3K 0.04% 236
2019
Q2 		$297K Buy
+17,519
New +$301K 0.06% 220
2019
Q1 		– Sell
-21,330
Closed -$271K – 214
2018
Q4 		$271K Buy
21,330
+301
+1% +$5.05K 0.05% 144
2018
Q3 		$451K Sell
21,029
-15,041
-42% -$321K 0.05% 138
2018
Q2 		$745K Sell
36,070
-3,184
-8% -$71.7K 0.66% 74
2018
Q1 		$988K Buy
39,254
+21,197
+117% +$515K 0.86% 44
2017
Q4 		$343K Sell
18,057
-392
-2% -$7.32K 0.43% 101
2017
Q3 		$341K Buy
18,449
+1,688
+10% +$29.2K 0.05% 124
2017
Q2 		$293K Buy
16,761
+2,633
+19% +$50.2K 0.04% 131
2017
Q1 		$263K Buy
14,128
+1,354
+11% +$26.1K 0.05% 156
2016
Q4 		$261K Buy
12,774
+3,012
+31% +$75.8K 0.08% 130
2016
Q3 		$292K Hold
9,762
– – 0.14% 103
2016
Q2 		$263K Buy
9,762
+1,377
+16% +$31.1K 0.2% 78
2016
Q1 		$157K Sell
8,385
-526
-6% -$10K 0.22% 115
2015
Q4 		$276K Buy
+8,911
New +$271K 0.76% 50

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Virtus ETF Advisers's MGNX Position: Q4 2024 in Review

Virtus ETF Advisers sold out of MacroGenics (MGNX) in Q4 2024, closing a stake of 19,694 shares — an estimated $64.8K sold.

Virtus ETF Advisers first reported a position in MGNX in Q4 2015 and held it in 29 quarters. The position peaked at $988K in Q1 2018. 128 funds tracked by Wall St. Rank hold MGNX as of Q4 2024.

  • Virtus ETF Advisers reported no remaining MacroGenics position as of Q4 2024 after selling out during the quarter.
  • Virtus ETF Advisers sold 19,694 MacroGenics shares in Q4 2024, an estimated $64.8K.
  • Virtus ETF Advisers first reported a position in MacroGenics in Q4 2015 and held it in 29 quarters.
  • Virtus ETF Advisers's MacroGenics position peaked at $988K in Q1 2018.
  • 128 funds tracked by Wall St. Rank held MacroGenics as of Q4 2024.

Based on Virtus ETF Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.